Advanced

Telcagepant provides new hope for people with migraine

Edvinsson, Lars LU (2009) In Nature Reviews Neurology 5(5). p.240-242
Abstract
The triptan drugs provide effective migraine relief for many people. nevertheless, a substantial number of migraine-affected individuals are unresponsive to triptans, and such therapy can also lead to an array of adverse effects. A new class of antimigraine drugs, currently undergoing clinical trials, could offer hope to those for whom triptan medication is unsuitable.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Nature Reviews Neurology
volume
5
issue
5
pages
240 - 242
publisher
Nature Publishing Group
external identifiers
  • wos:000265854700002
  • scopus:68349089395
ISSN
1759-4766
DOI
10.1038/nrneurol.2009.49
language
English
LU publication?
yes
id
bcd6b8d2-8cdc-4a80-b5ba-9901aca2daa0 (old id 1426330)
date added to LUP
2009-06-29 15:40:43
date last changed
2017-01-01 04:30:47
@misc{bcd6b8d2-8cdc-4a80-b5ba-9901aca2daa0,
  abstract     = {The triptan drugs provide effective migraine relief for many people. nevertheless, a substantial number of migraine-affected individuals are unresponsive to triptans, and such therapy can also lead to an array of adverse effects. A new class of antimigraine drugs, currently undergoing clinical trials, could offer hope to those for whom triptan medication is unsuitable.},
  author       = {Edvinsson, Lars},
  issn         = {1759-4766},
  language     = {eng},
  number       = {5},
  pages        = {240--242},
  publisher    = {Nature Publishing Group},
  series       = {Nature Reviews Neurology},
  title        = {Telcagepant provides new hope for people with migraine},
  url          = {http://dx.doi.org/10.1038/nrneurol.2009.49},
  volume       = {5},
  year         = {2009},
}